ModelEdge

Cidara Therapeutics Inc.
CDTX
Filing Type10-Q
Filing Date8/12/2024
Updated8/13/24, 2:15 PM

Filing

10-Q
Earnings Release

Exhibits

10-QQ2
EX-10.32020 INDUCEMENT INCENTIVE PLAN, AS AMENDED
EX-10.4LICENSE AND TECHNOLOGY AGREEMENT
EX-31.1CERTIFICATION OF CEO PURSUANT TO SECURITIES EXCHANGE ACT OF 1934
EX-31.2CERTIFICATION OF CFO PURSUANT TO SECURITIES EXCHANGE ACT OF 1934
EX-32.1CERTIFICATION OF CEO PURSUANT TO SARBANES-OXLEY ACT OF 2002
EX-32.2CERTIFICATION OF CFO PURSUANT TO SARBANES-OXLEY ACT OF 2002
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic